China is Quietly Becoming the World’s Pharmacy — and There Are Big Risks

Cathalijne Adams

Cathalijne Adams Researcher/Writer, AAM

I’ve spent hours researching the health impacts of various vitamins, supplements and medications, weighing the costs and benefits of various options of each... until I end up researching how to cure a headache as well.  

Yet, I’ve neglected researching one major element of my health that you probably have, too – the pharmaceutical and over-the-counter drugs (OTC) that have become so critical to modern health.

I’ve always just assumed that medications and vitamins would be one of the most closely scrutinized and regulated elements under the purview of the Food and Drug Administration (FDA).

Sure, that fish oil supplement may not actually do anything for my heart, but it won’t be detrimental to my health, right? Right!?!

But just this week, the FDA announced a voluntary recall of a generic, commonly prescribed blood pressure medication, Valsartan, that may have been contaminated by the carcinogenic toxin N-nitrosodimethylamine (NDMA).

All of the Valsartan flagged for recall by the FDA was manufactured in China, which turns out to be the source of most of America’s drugs.

Tragically, this isn’t the first time the FDA has missed contaminates in America’s drug supply. A decade ago, 246 people died in the aftermath of a tainted blood thinner, Heparin, that had also been manufactured in China.

Eighty percent of active ingredients in America’s pharmaceutical and OTC drugs — you know, the stuff that actually makes your medicine work — come from China and India, according to Rosemary Gibson and Janardan Prasad Singh, authors of the new book China RX: Exposing the Risks of America’s Dependence on China for Medicine.

With production so far away, the FDA is understandably challenged in conducting frequent and thorough inspections of drug manufacturing facilities overseas. That makes the need to secure drug manufacturing in the United States all the more imperative.

“The FDA says drugs are safe. But the outsourcing of America’s medicine making is so complex it seems impossible to ensure that they are safe,” Gibson and Singh write.

Many of the drugs that Americans depend upon, including birth control pills, antibiotics like penicillin, vitamin C and even cancer drugs, are made in China with little regulation.

Even more alarmingly, China is aiming to become the world’s pharmacy, part of its “Made in China 2025” industry plan.

As President Donald Trump contemplates opening the way for more imported drugs to enter the United States, it is critical that we think carefully about how to protect America’s drug manufacturing, which Gibson and Signh show has been systemically undercut by Chinese competitors.


Reposted from AAM

Posted In: Allied Approaches, From Alliance for American Manufacturing

Union Matters

He Gets the Bucks, We Get All the Deadly Bangs

Sam Pizzigati

Sam Pizzigati Editor, Too Much online magazine

National Rifle Association chief Wayne LaPierre has had better weeks. First came the horrific early August slaughters in California, Texas, and Ohio that left dozens dead, murders that elevated public pressure on the NRA’s hardline against even the mildest of moves against gun violence. Then came revelations that LaPierre — whose labors on behalf of the nonprofit NRA have made him a millionaire many times over — last year planned to have his gun lobby group bankroll a 10,000-square-foot luxury manse near Dallas for his personal use. In response, LaPierre had his flacks charge that the NRA’s former ad agency had done the scheming to buy the mansion. The ad agency called that assertion “patently false” and related that LaPierre had sought the agency’s involvement in the scheme, a request the agency rejected. The mansion scandal, notes the Washington Post, comes as the NRA is already “contending with the fallout from allegations of lavish spending by top executives.”


More ...

Corruption Coordinates

Corruption Coordinates